GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bespoke Extracts Inc (OTCPK:BSPK) » Definitions » Altman Z2-Score

BSPK (Bespoke Extracts) Altman Z2-Score : -306.40 (As of Dec. 12, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Bespoke Extracts Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

Bespoke Extracts has a Altman Z2-Score of -306.40, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Bespoke Extracts's Altman Z2-Score or its related term are showing as below:

BSPK' s Altman Z2-Score Range Over the Past 10 Years
Min: -5636.11   Med: -274.49   Max: 145.08
Current: -306.4

During the past 13 years, Bespoke Extracts's highest Altman Z2-Score was 145.08. The lowest was -5636.11. And the median was -274.49.


Bespoke Extracts Altman Z2-Score Historical Data

The historical data trend for Bespoke Extracts's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bespoke Extracts Altman Z2-Score Chart

Bespoke Extracts Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -339.78 -557.34 -591.44 -270.09 -280.82

Bespoke Extracts Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -263.83 -280.82 -284.03 -277.47 -306.40

Competitive Comparison of Bespoke Extracts's Altman Z2-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Bespoke Extracts's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bespoke Extracts's Altman Z2-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bespoke Extracts's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Bespoke Extracts's Altman Z2-Score falls into.



Bespoke Extracts Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Bespoke Extracts's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*-4.7456+3.26*-77.5651+6.72*-3.1982+1.05*-0.8733
=-306.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Sep. 2024:
Total Assets was $0.34 Mil.
Total Current Assets was $0.12 Mil.
Total Current Liabilities was $1.73 Mil.
Retained Earnings was $-26.22 Mil.
Pre-Tax Income was -0.276 + -0.261 + -0.314 + -0.269 = $-1.12 Mil.
Interest Expense was -0.013 + -0.011 + -0.011 + -0.004 = $-0.04 Mil.
Total Liabilities was $2.67 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(0.124 - 1.728)/0.338
=-4.7456

X2=Retained Earnings/Total Assets
=-26.217/0.338
=-77.5651

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-1.12 - -0.039)/0.338
=-3.1982

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(-2.329 - 0)/2.667
=-0.8733

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Bespoke Extracts has a Altman Z2-Score of -306.40 indicating it is in Distress Zones.


Bespoke Extracts  (OTCPK:BSPK) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Bespoke Extracts Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of Bespoke Extracts's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Bespoke Extracts Business Description

Traded in Other Exchanges
N/A
Address
12001 E. 33rd Avenue, Unit O, Aurora, Denver, CO, USA, 80010
Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products. It unveiled a new brand image and a new line-up of seven hemp-derived CBD formulations available for purchase in the form of tinctures and softgels.
Executives
Michael Feinsod director, 10 percent owner, officer: CEO
Tyler Hunter Garth director, officer: President 6300 E HAMPDEN AVE, 2306, DENVER CO 80222
Danil Pollack 10 percent owner, officer: President and CEO 6 GAUGUIN AVE., VAUGHAN A6 L4J9J7
Niquana Monique Noel 10 percent owner, officer: President and CEO 1316 SW 3RD COURT, FT. LAUDERDALE FL 33312
Marc Yahr director, 10 percent owner, officer: President and CEO 1966 NE 123RD STREET, NUM 170, NORTH MIAMI FL 33181
Anthony Ivankovich 10 percent owner 971 CRANDON BLVD., APT. PH-6, KEY BISCAYNE FL 33149
Mcglothlin Holdings, Ltd. 10 percent owner 402 W. DAVIS, LULING TX 78648
Barry Tenzer director, 10 percent owner, officer: President, CEO, CFO 290 LENOX AVENUE, NEW YORK NY 10027
Roberto Fata director, 10 percent owner, officer: Executive VP 290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027
Lyle Hauser 10 percent owner 290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027